{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:15Z","timestamp":1786119615688,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1097\/md.0000000000006397","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T18:24:46Z","timestamp":1490207086000},"page":"e6397","source":"Crossref","is-referenced-by-count":9,"title":["Drug-coated balloon in combination with bare metal stent strategy for de novo coronary artery disease"],"prefix":"10.1097","volume":"96","author":[{"given":"Wenjie","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xule","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20210226","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4244\/EIJV9I5A98","article-title":"Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial","volume":"9","author":"Waksman","year":"2013","journal-title":"EuroIntervention"},{"key":"R2-36-20210226","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.carrev.2012.06.001","article-title":"One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)","volume":"13","author":"Mieres","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"R3-36-20210226","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","article-title":"A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent)","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R4-36-20210226","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study","volume":"60","author":"Latib","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R5-36-20210226","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4244\/EIJV9I5A99","article-title":"Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?","volume":"9","author":"Unverdorben","year":"2013","journal-title":"EuroIntervention"},{"key":"R6-36-20210226","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carrev.2015.07.009","article-title":"Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study","volume":"16","author":"Worthley","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"R7-36-20210226","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00392-015-0957-6","article-title":"Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial","volume":"105","author":"Kleber","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"R8-36-20210226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.293.2.165","article-title":"Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial","volume":"293","author":"Kastrati","year":"2005","journal-title":"JAMA"},{"key":"R9-36-20210226","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients","volume":"6","author":"Tada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R10-36-20210226","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"R11-36-20210226","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ahj.2013.08.023","article-title":"Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial","volume":"166","author":"Liistro","year":"2013","journal-title":"Am Heart J"},{"key":"R12-36-20210226","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ccd.25184","article-title":"Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent","volume":"84","author":"Clever","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"R13-36-20210226","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R14-36-20210226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1258\/1355819021927674","article-title":"Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice","volume":"7","author":"Higgins","year":"2002","journal-title":"J Health Serv Res Policy"},{"key":"R15-36-20210226","first-page":"45","article-title":"[Introduction to traditional meta-analysis]","volume":"34","author":"Bolanos Diaz","year":"2014","journal-title":"Rev Gastroenterol Peru"},{"key":"R16-36-20210226","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCINTERVENTIONS.108.827865.108.827865","article-title":"Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation","volume":"2","author":"Herdeg","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"R17-36-20210226","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/joic.12210","article-title":"Stenting and adjunctive delivery of paclitaxel via balloon coating versus durable polymeric matrix for de novo coronary lesions: clinical and angiographic results from the prospective randomized trial","volume":"28","author":"Zurakowski","year":"2015","journal-title":"J Interv Cardiol"},{"key":"R18-36-20210226","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.jacc.2012.02.027","article-title":"First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes","volume":"59","author":"Belkacemi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R19-36-20210226","first-page":"2157","article-title":"PEPCAD III: a randomised trial comparing a paclitaxel-coated balloon\/stent system with a sirolimus eluting stent","volume":"120","author":"Hamm","year":"2009","journal-title":"Circulation"},{"key":"R20-36-20210226","doi-asserted-by":"crossref","first-page":"K83","DOI":"10.4244\/EIJV7SKA15","article-title":"Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus","volume":"7","author":"Ali","year":"2011","journal-title":"EuroIntervention"},{"key":"R21-36-20210226","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/ccd.23499","article-title":"A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial","volume":"80","author":"Stella","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"R22-36-20210226","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4244\/EIJV10I1A10","article-title":"A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results","volume":"10","author":"Lopez Minguez","year":"2014","journal-title":"EuroIntervention"},{"key":"R23-36-20210226","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/CIRCINTERVENTIONS.113.001146","article-title":"Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up","volume":"7","author":"Poerner","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"R24-36-20210226","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00380-015-0671-3","article-title":"Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial","volume":"31","author":"Burzotta","year":"2016","journal-title":"Heart Vessels"},{"key":"R25-36-20210226","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"R26-36-20210226","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med"},{"key":"R27-36-20210226","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ijcard.2012.01.080","article-title":"Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses","volume":"167","author":"D\u2019Ascenzo","year":"2013","journal-title":"Int J Cardiol"},{"key":"R28-36-20210226","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R29-36-20210226","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCINTERVENTIONS.108.797928","article-title":"Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses","volume":"1","author":"Hamilos","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"R30-36-20210226","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2165\/11316500-000000000-00000","article-title":"Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment","volume":"32","author":"Byrne","year":"2009","journal-title":"Drug Saf"},{"key":"R31-36-20210226","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jjcc.2014.05.007","article-title":"Drug-eluting balloons in patients with non-ST elevation acute coronary syndrome","volume":"65","author":"Besic","year":"2015","journal-title":"J Cardiol"},{"key":"R32-36-20210226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00392-009-0101-6","article-title":"Treatment of small coronary arteries with a paclitaxel-coated balloon catheter","volume":"99","author":"Unverdorben","year":"2010","journal-title":"Clin Res Cardiol"},{"key":"R33-36-20210226","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ihj.2013.08.011","article-title":"The paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: an angiographic follow up study","volume":"65","author":"Kaul","year":"2013","journal-title":"Indian Heart J"},{"key":"R34-36-20210226","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5603\/CJ.a2016.0018","article-title":"Time course of vascular response after an a priori strategy of bare metal stent implantation post-dilated with a paclitaxel-coated balloon: implementation of a three-dimensional analysis algorithm with optical coherence tomography","volume":"23","author":"Otto","year":"2016","journal-title":"Cardiol J"},{"key":"R35-36-20210226","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4244\/EIJV8I4A71","article-title":"Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study","volume":"8","author":"Fischer","year":"2012","journal-title":"EuroIntervention"},{"key":"R36-36-20210226","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4244\/EIJV7I6A114","article-title":"Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first","volume":"7","author":"Gutierrez-Chico","year":"2011","journal-title":"EuroIntervention"},{"key":"R37-36-20210226","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4244\/EIJV8I4A70","article-title":"Comparison of two drug-eluting balloons: a report from the SCAAR registry","volume":"8","author":"Bondesson","year":"2012","journal-title":"EuroIntervention"},{"key":"R38-36-20210226","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ccd.22468","article-title":"Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries","volume":"76","author":"Posa","year":"2010","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000006397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:00:11Z","timestamp":1786042811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201703240-00036"}},"subtitle":["A PRISMA-compliant meta-analysis of randomized clinical trials"],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000006397","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}